Morgan Lewis’s Albert Lung is quoted in this feature article discussing the Securities and Exchange Commission’s (SEC) efforts to simplify public company disclosure. Albert notes that “this change would benefit technology and life sciences companies he advises, many of whom entered into research and licensing agreements containing sensitive information.”